Guidelines for the management of patients with invasive candidiasis and mucosal candidiasis were prepared
by an Expert Panel of the Infectious Diseases Society of America. These updated guidelines replace the previous
guidelines published in the 15 January 2004 issue of Clinical Infectious Diseases and are intended for use by
health care providers who care for patients who either have or are at risk of these infections. Since 2004,
several new antifungal agents have become available, and several new studies have been published relating to
the treatment of candidemia, other forms of invasive candidiasis, and mucosal disease, including oropharyngeal
and esophageal candidiasis. There are also recent prospective data on the prevention of invasive candidiasis
in high-risk neonates and adults and on the empiric treatment of suspected invasive candidiasis in adults.
This new information is incorporated into this revised document.
EXECUTIVE SUMMARY